Literature DB >> 16650328

High case-fatality rates of meningococcal disease in Western Norway caused by serogroup C strains belonging to both sequence type (ST)-32 and ST-11 complexes, 1985-2002.

I Smith1, D A Caugant, E A Høiby, T Wentzel-Larsen, A Halstensen.   

Abstract

A total of 293 meningococcal disease (McD) patients from Western Norway hospitalized during 1985-2002 were examined for risk factors related to death. The case-fatality rate (CFR) increased from 4% during 1985-1993 to 17% during 1994-2002. We analysed the phenotypic and genotypic characteristics of the meningococcal patient isolates, with the aim of identifying whether highly virulent meningococcal strains contributed to the increased CFR. The Norwegian epidemic strain B:15:P1.7,16/ST-32 complex was overall the most common phenotype/genotype (n=75) and caused most deaths (n=9; CFR 12.0%). However, fatality was significantly associated with disease caused by serogroup C meningococcal strains; C:15:P1.7,16/ST-32 and C:2a/ST-11 complex strains, which had the highest CFRs of 21.1% and 18.2% respectively. Serogroup B strains of the ST-32 complex differing by serotype and/or serosubtype from the epidemic strain had a CFR of 5.1%, while the CFR of disease caused by other strains (all phenotypes and genotypes pooled) was 2.2%. The distribution of phenotypes/clonal complexes varied significantly between 1985-1993 and 1994-2002 (P<0.001); B:15/ST-32 complex strains decreased whereas both C:15:P1.7,16/ST-32 complex strains and strains with other phenotypes/clonal complexes increased. Our results indicate that C:15:P1.7,16/ST-32 and C:2a/ST-11 complex strains were highly virulent strains and contributed to the high CFR of McD in patients from Western Norway. To reduce fatality, rapid identification of such virulent strains is necessary. In addition, early and specific measures should include public information, vaccination of populations at risk of disease and carriage eradication, when clustering of patients occurs.

Entities:  

Mesh:

Year:  2006        PMID: 16650328      PMCID: PMC2870511          DOI: 10.1017/S0950268806006248

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  37 in total

1.  Serotyping and subtyping of Neisseria meningitidis isolates by co-agglutination, dot-blotting and ELISA.

Authors:  E Wedege; E A Høiby; E Rosenqvist; L O Frøholm
Journal:  J Med Microbiol       Date:  1990-03       Impact factor: 2.472

2.  The epidemiology of meningococcal disease in Norway 1975-91.

Authors:  A Lystad; S Aasen
Journal:  NIPH Ann       Date:  1991-12

Review 3.  Methods of multilocus enzyme electrophoresis for bacterial population genetics and systematics.

Authors:  R K Selander; D A Caugant; H Ochman; J M Musser; M N Gilmour; T S Whittam
Journal:  Appl Environ Microbiol       Date:  1986-05       Impact factor: 4.792

4.  Intercontinental spread of a genetically distinctive complex of clones of Neisseria meningitidis causing epidemic disease.

Authors:  D A Caugant; L O Frøholm; K Bøvre; E Holten; C E Frasch; L F Mocca; W D Zollinger; R K Selander
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

5.  Clones of serogroup B Neisseria meningitidis causing systemic disease in The Netherlands, 1958-1986.

Authors:  D A Caugant; P Bol; E A Høiby; H C Zanen; L O Frøholm
Journal:  J Infect Dis       Date:  1990-10       Impact factor: 5.226

6.  Intercontinental spread of Neisseria meningitidis clones of the ET-5 complex.

Authors:  D A Caugant; L O Frøholm; K Bøvre; E Holten; C E Frasch; L F Mocca; W D Zollinger; R K Selander
Journal:  Antonie Van Leeuwenhoek       Date:  1987       Impact factor: 2.271

7.  Ongoing group B Neisseria meningitidis epidemic in São Paulo, Brazil, due to increased prevalence of a single clone of the ET-5 complex.

Authors:  C T Sacchi; L L Pessoa; S R Ramos; L G Milagres; M C Camargo; N T Hidalgo; C E Melles; D A Caugant; C E Frasch
Journal:  J Clin Microbiol       Date:  1992-07       Impact factor: 5.948

8.  Emergence of a virulent clone of Neisseria meningitidis serotype 2a that is associated with meningococcal group C disease in Canada.

Authors:  F E Ashton; J A Ryan; A Borczyk; D A Caugant; L Mancino; D Huang
Journal:  J Clin Microbiol       Date:  1991-11       Impact factor: 5.948

9.  Incidence, serogroups and case-fatality rate of invasive meningococcal infections in a Swedish region 1975-1989.

Authors:  S Berg; B Trollfors; K Alestig; U Jodal
Journal:  Scand J Infect Dis       Date:  1992

10.  Association of meningococcal serogroups with the course of disease in the Netherlands, 1959-83.

Authors:  L Spanjaard; P Bol; S de Marie; H C Zanen
Journal:  Bull World Health Organ       Date:  1987       Impact factor: 9.408

View more
  8 in total

1.  Serogroup-specific interaction of Neisseria meningitidis capsular polysaccharide with host cell microtubules and effects on tubulin polymerization.

Authors:  Adelfia Talà; Laura Cogli; Mario De Stefano; Marcella Cammarota; Maria Rita Spinosa; Cecilia Bucci; Pietro Alifano
Journal:  Infect Immun       Date:  2013-10-28       Impact factor: 3.441

Review 2.  Evolutionary and genomic insights into meningococcal biology.

Authors:  Holly B Bratcher; Julia S Bennett; Martin C J Maiden
Journal:  Future Microbiol       Date:  2012-07       Impact factor: 3.165

3.  Meningococcal disease: shifting epidemiology and genetic mechanisms that may contribute to serogroup C virulence.

Authors:  Jessica R Macneil; Jennifer D Thomas; Amanda C Cohn
Journal:  Curr Infect Dis Rep       Date:  2011-08       Impact factor: 3.725

Review 4.  The elusive meningococcal meningitis serogroup: a systematic review of serogroup B epidemiology.

Authors:  Vanessa N Racloz; Silva J D Luiz
Journal:  BMC Infect Dis       Date:  2010-06-17       Impact factor: 3.090

5.  Pre-admission clinical course of meningococcal disease and opportunities for the earlier start of appropriate intervention: a prospective epidemiological study on 752 patients in the Netherlands, 2003-2005.

Authors:  S C de Greeff; H E de Melker; L M Schouls; L Spanjaard; M van Deuren
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-05-21       Impact factor: 3.267

6.  Draft Genome Sequence of C:P1.5-1,10-8:F3-6:ST-11 Meningococcal Clinical Isolate Associated with a Cluster on a Cruise Ship.

Authors:  A Neri; C Fazio; A Ciammaruconi; A Anselmo; A Fortunato; A Palozzi; P Vacca; S Fillo; F Lista; P Stefanelli
Journal:  Genome Announc       Date:  2014-12-04

7.  The Clinical Picture and Severity of Invasive Meningococcal Disease Serogroup W Compared With Other Serogroups in the Netherlands, 2015-2018.

Authors:  Anna D Loenenbach; Arie van der Ende; Hester E de Melker; Elisabeth A M Sanders; Mirjam J Knol
Journal:  Clin Infect Dis       Date:  2020-05-06       Impact factor: 9.079

8.  Emergence of serogroup C meningococcal disease associated with a high mortality rate in Hefei, China.

Authors:  Xi-Hai Xu; Ying Ye; Li-Fen Hu; Yu-Hui Jin; Qin-Qin Jiang; Jia-Bin Li
Journal:  BMC Infect Dis       Date:  2012-09-04       Impact factor: 3.090

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.